[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644466":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":69,"collaborators":20,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":80,"minAge":81,"maxAge":20,"enrollmentInfo":82,"targetDuration":20,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":51,"whyStopped":20,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study Participants","EXPERIMENTAL","Study participants will be persons who have late period of up to 21 days",[13],"Drug: Mifepristone + Misoprostol",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Mifepristone + Misoprostol","Study participants are given mifepristone and misoprostol for menstrual regulation.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Ushma D Upadhyay, PhD, MPH","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","415-353-4626","ushma.upadhyay@ucsf.edu",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Jennifer Ko, MLIS","415-353-9113","jennifer.ko@ucsf.edu",[35,49],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":20},"UCSF Advancing New Standards in Reproductive Health (ANSIRH)","ACTIVE_NOT_RECRUITING","Oakland","California","94612","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-122.2708,37.80437,{"lat":47,"lon":46},{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":41,"countryCode":42,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Roanoke Health Center","RECRUITING","Roanoke","Virginia","24017",{"type":44,"coordinates":56},[57,58],-79.94143,37.27097,{"lat":58,"lon":57},[61,65],{"name":62,"role":27,"phone":63,"phoneExt":20,"email":64},"Christine Hernández, MPH, MPM, CPHQ","828-280-5723","christina.hernandez@ppsat.org",{"name":66,"role":27,"phone":67,"phoneExt":20,"email":68},"Matthew Zerden, MD, MPH","617-935-2394","matthew.zerden@ppsat.org",{"type":24,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Ushma Upadhyay","Principal Investigator","100644466","phase-4-period-pills-for-menstrual-regulation-a-new-reproductive-health-option-100644466",false,"NCT07671989","Period Pills for Menstrual Regulation: A New Reproductive Health Option","Period Pills","Inclusion Criteria:\n\n* Be 18 years old or older\n* Read and speak English\n* Know the date of their last menstrual period within 2 days\n* Have a period that is late by up to 21 days\n* Must have had regular periods in the last 4 months\n* Does not want to be pregnant\n* Does not want to verify pregnancy status\n* Understand that if they are pregnant, the pills will end their pregnancy\n* Does not have contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)\n\nExclusion Criteria:\n\n* Under 18 years old\n* Does not read and speak English\n* Does not know the date of their last menstrual period within 2 days\n* Has not had regular periods in the last 4 months\n* Wants to be pregnant\n* Wants to verify pregnancy status\n* Does not display understanding that if they are pregnant, the pills will end their pregnancy\n* Has any contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)",true,"FEMALE","18 Years",{"count":83,"type":84},100,"ESTIMATED","INTERVENTIONAL",[87],"PHASE4","The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.",[90,91],"Menstrual Regulation","Menstrual Health Intervention",[93,94,95],"late period","missed period","mestruation","2026-06-22",{"date":98,"type":99},"2026-06-26","ACTUAL",{"date":96,"type":99},{"date":102,"type":84},"2027-05-31",{"name":5,"class":6},2]